These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer. Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250 [TBL] [Abstract][Full Text] [Related]
27. An optimized procedure for exosome isolation and analysis using serum samples: Application to cancer biomarker discovery. Li M; Rai AJ; DeCastro GJ; Zeringer E; Barta T; Magdaleno S; Setterquist R; Vlassov AV Methods; 2015 Oct; 87():26-30. PubMed ID: 25814440 [TBL] [Abstract][Full Text] [Related]
28. The Panel of 12 Cell-Free MicroRNAs as Potential Biomarkers in Prostate Neoplasms. Konoshenko MY; Lekchnov EA; Bryzgunova OE; Zaporozhchenko IA; Yarmoschuk SV; Pashkovskaya OA; Pak SV; Laktionov PP Diagnostics (Basel); 2020 Jan; 10(1):. PubMed ID: 31936850 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of optimal extracellular vesicle small RNA isolation and qRT-PCR normalisation for serum and urine. Crossland RE; Norden J; Bibby LA; Davis J; Dickinson AM J Immunol Methods; 2016 Feb; 429():39-49. PubMed ID: 26723490 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214. Srivastava A; Goldberger H; Dimtchev A; Ramalinga M; Chijioke J; Marian C; Oermann EK; Uhm S; Kim JS; Chen LN; Li X; Berry DL; Kallakury BV; Chauhan SC; Collins SP; Suy S; Kumar D PLoS One; 2013; 8(10):e76994. PubMed ID: 24167554 [TBL] [Abstract][Full Text] [Related]
31. Detection of miRNAs in urine of prostate cancer patients. Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485 [TBL] [Abstract][Full Text] [Related]
33. Can urinary exosomes act as treatment response markers in prostate cancer? Mitchell PJ; Welton J; Staffurth J; Court J; Mason MD; Tabi Z; Clayton A J Transl Med; 2009 Jan; 7():4. PubMed ID: 19138409 [TBL] [Abstract][Full Text] [Related]
34. Aqueous two-phase system to isolate extracellular vesicles from urine for prostate cancer diagnosis. Shin H; Park YH; Kim YG; Lee JY; Park J PLoS One; 2018; 13(3):e0194818. PubMed ID: 29584777 [TBL] [Abstract][Full Text] [Related]
35. Data analysis algorithm for the development of extracellular miRNA-based diagnostic systems for prostate cancer. Bryzgunova OE; Zaporozhchenko IA; Lekchnov EA; Amelina EV; Konoshenko MY; Yarmoschuk SV; Pashkovskaya OA; Zheravin AA; Pak SV; Rykova EY; Laktionov PP PLoS One; 2019; 14(4):e0215003. PubMed ID: 30970027 [TBL] [Abstract][Full Text] [Related]
36. Extracellular vesicles mediate intercellular communication: Transfer of functionally active microRNAs by microvesicles into phagocytes. Claßen L; Tykocinski LO; Wiedmann F; Birr C; Schiller P; Tucher C; Krienke S; Raab MS; Blank N; Lorenz HM; Schiller M Eur J Immunol; 2017 Sep; 47(9):1535-1549. PubMed ID: 28665018 [TBL] [Abstract][Full Text] [Related]
37. Size Dependent Lipidomic Analysis of Urinary Exosomes from Patients with Prostate Cancer by Flow Field-Flow Fractionation and Nanoflow Liquid Chromatography-Tandem Mass Spectrometry. Yang JS; Lee JC; Byeon SK; Rha KH; Moon MH Anal Chem; 2017 Feb; 89(4):2488-2496. PubMed ID: 28192938 [TBL] [Abstract][Full Text] [Related]
38. Study of circulating microRNA-125b levels in serum exosomes in advanced melanoma. Alegre E; Sanmamed MF; Rodriguez C; Carranza O; Martín-Algarra S; González A Arch Pathol Lab Med; 2014 Jun; 138(6):828-32. PubMed ID: 24878024 [TBL] [Abstract][Full Text] [Related]
39. Specific and Generic Isolation of Extracellular Vesicles with Magnetic Beads. Pedersen KW; Kierulf B; Neurauter A Methods Mol Biol; 2017; 1660():65-87. PubMed ID: 28828649 [TBL] [Abstract][Full Text] [Related]
40. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer. Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]